SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Tatiana Dilla, Jörgen Möller, Paul O’Donohoe, María Álvarez, José A Sacristán, Michael Happich, Antje Tockhorn, Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison, BMC Psychiatry, 2014, 14, 1

    CrossRef

  2. 2
    Jamie Karagianis, Richard Williams, Lori Davis, Ric Procyshyn, Neerav Monga, James Hanley, Ranjith Chandrasena, Aruna Thakur, Ruth Dickson, Antipsychotic switching: results from a one-year prospective, observational study of patients with schizophrenia, Current Medical Research and Opinion, 2009, 25, 9, 2121

    CrossRef

  3. 3
    Donald L. Patrick, Tom Burns, Pierluigi Morosini, Margaret Rothman, Dennis D. Gagnon, Diane Wild, Ines Adriaenssen, Reliability, validity and ability to detect change of the clinician-rated Personal and Social Performance scale in patients with acute symptoms of schizophrenia, Current Medical Research and Opinion, 2009, 25, 2, 325

    CrossRef

  4. 4
    The Maudsley Prescribing Guidelines, Tenth Edition, 2009,

    CrossRef

  5. 5
    Diego Novick, Josep Maria Haro, David Suarez, João Marques-Teixeira, Dieter Naber, Clinical consequences of switching antipsychotic drugs in outpatients with schizophrenia: 36-month results from the European Schizophrenia Outpatient Health Outcomes study, International Clinical Psychopharmacology, 2008, 23, 4, 203

    CrossRef

  6. 6
    J.M. Haro, D. Novick, D. Suarez, S. Ochoa, M. Roca, Predictors of the course of illness in outpatients with schizophrenia: A prospective three year study, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2008, 32, 5, 1287

    CrossRef

  7. 7
    Paul B. Fitzgerald, William Montgomery, Anthony R. de Castella, Kate M. Filia, Sacha L. Filia, Laura Christova, Dan Jackson, Jayashri Kulkarni, Australian Schizophrenia Care and Assessment Programme: real-world schizophrenia: economics, Australian and New Zealand Journal of Psychiatry, 2007, 41, 10, 819

    CrossRef

  8. 8
    Jayashri Kulkarni, Anthony R. de Castella, Kate M. Filia, Sacha L. Filia, Natasha Marston, William Montgomery, Laura Christova, Paul B. Fitzgerald, Australian Schizophrenia Care and Assessment Programme: real-world schizophrenia: outcomes, Australian and New Zealand Journal of Psychiatry, 2007, 41, 12, 969

    CrossRef

  9. 9
    S. Levander, J. Eberhard, E. Lindström, Clinical decision-making during 5 years of antipsychotic treatment, Acta Psychiatrica Scandinavica, 2007, 116,
  10. 10
    H. POON, V. ELLIOT, D.N. BATEMAN, W.S. WARING, IMPACT OF LEGISLATIVE CHANGES ON PATTERNS OF ANTIPSYCHOTIC PRESCRIBING AND SELF-POISONING IN SCOTLAND: 2000-06, The Journal of Toxicological Sciences, 2007, 32, 1, 1

    CrossRef

  11. 11
    Yvette Kusel, Richard Laugharne, Sian Perrington, Jan McKendrick, Deborah Stephenson, J. Stockton-Henderson, Madeline Barley, R. McCaul, Tom Burns, Measurement of quality of life in schizophrenia: a comparison of two scales, Social Psychiatry and Psychiatric Epidemiology, 2007, 42, 10, 819

    CrossRef

  12. 12
    P. Gutierrez-Recacha, D. Chisholm, J. M. Haro, L. Salvador-Carulla, J. L. Ayuso-Mateos, Cost-effectiveness of different clinical interventions for reducing the burden of schizophrenia in Spain, Acta Psychiatrica Scandinavica, 2006, 114,
  13. 13
    R. Nesvåg, M. Hendset, H. Refsum, L. Tanum, Serum concentrations of risperidone and 9-OH risperidone following intramuscular injection of long-acting risperidone compared with oral risperidone medication, Acta Psychiatrica Scandinavica, 2006, 114, 1
  14. 14
    R. Chaplin, M. Barley, S. J. Cooper, Y. Kusel, J. McKendrick, D. Stephenson, T. Obuaya, J. Stockton-Henderson, L. S. O'Brien, T. Burns, The impact of intellectual functioning on symptoms and service use in schizophrenia, Journal of Intellectual Disability Research, 2006, 50, 4